CRGX CARGO Therapeutics
- 15.430
- -0.490-3.08%
CARGO Therapeutics News
Express News | CARGO Therapeutics: Files for Prospectus Related to Resale by Selling Stockholders of up to 6.5 Mln Shares of Common Stock- SEC Filing
Express News | CARGO Therapeutics Inc - Board Approved an Increase in Number of Authorized Directors on Board From Seven to Eight
Express News | CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors With the Appointment of Jane Pritchett Henderson as Independent Director
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
Cargo Therapeutics Shares Drop 17% After Private Placement News
By Stephen Nakrosis Shares of biotechnology company Cargo Therapeutics were trading in the red late in Tuesday's regular session, following news the company entered a securities purchase agreement fo
Express News | CARGO Therapeutics Shares Are Trading Lower After the Company Announced It Entered Into a Securities Purchase Agreement for a Private Investment in Public Equity Financing That Is Expected to Result in Gross Proceeds of Approximately $110.0 Million
Express News | CARGO Therapeutics Entered Into Security Purchase Agreement For Private Investment With Expectations To Result In Gross Proceeds Of ~ $110.0M
CARGO Therapeutics to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ:CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer
Express News | CARGO Therapeutics: Extends Cash Runway Through 2026
CARGO Therapeutics to Sell 6.5M Shares at $17.0 Per Share >CRGX
CARGO Therapeutics to Sell 6.5M Shares at $17.0 Per Share >CRGX
CARGO Therapeutics Enters Into Securities Purchase Agreement Expected to Result in Gross Proceeds of Around $110M >CRGX
CARGO Therapeutics Enters Into Securities Purchase Agreement Expected to Result in Gross Proceeds of Around $110M >CRGX
Express News | CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Cargo Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 52.45% Truist Securities $34 → $32 Reiterates Buy → Buy 03/22/2024 52.45% Jefferies $28 → $32 M
Analysts Offer Insights on Healthcare Companies: CARGO Therapeutics, Inc. (CRGX), Helius Medical Technologies (HSDT) and CareCloud (CCLD)
Express News | CARGO Therapeutics Inc : Truist Securities Cuts Target Price to $32 From $34
Express News | CARGO Therapeutics: As of March 31, Had Cash, Cash Equivalents & Marketable Securities of $375.9 Mln, Providing Expected Cash Runway Into 2026
CARGO Therapeutics | 10-Q: Quarterly report
Express News | Cargo Therapeutics Q1 2024 Adj EPS $(0.87) Beats $(1.05) Estimate
Express News | CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Analysis
Price Target
No Data
